A future without Alzheimer's

The race is on. Alzheimer's and related dementias research is a dynamic field, and momentum builds each year. This site is for professional researchers and anyone interested in following the progress in research. The Alzheimer's Association has been involved in every major advancement in Alzheimer's and related dementias research since the 1980's and is a leader in the global fight for a world without Alzheimer's.

what we know today

tomorrow's answers

clinical trials

• About Alzheimer's disease
• Changes inside the brain
• Causes
• Current drug treatments

• Drug treatment pipeline
• Earlier diagnosis
• Prevention
• Our funding strategy

• Find a trial
• Why participate
• How trials work
• TrialMatch^®

May 7, 2013

Baxter's Alzheimer's disease drug fails in late-stage trial
— Reuters

April 17, 2013

Family history of Alzheimer's associated with abnormal brain pathology
- ScienceDaily

April 9, 2013

Alzheimer's genetics in African Americans
- Alzheimer’s Association Research Update

Gene may double risk of Alzheimer's in blacks
- HealthDay

April 2, 2013

Obama launches research initiative to study human brain
- Reuters

March 19, 2013

New Alzheimer's Association report reveals 1 in 3 seniors dies with Alzheimer's or another dementia
- Alzheimer's Association

Alzheimer's Association International Conference

Make history at AAIC 2013 in Boston, United States, July 13-18, 2013.

• Register today

2013 Research Grant Program Announcement

Application procedures and key dates now available

Global Alzheimer's Association Interactive Network

A collaborative project to transform the way scientists work together

Alzheimer's Association TrialMatch™

A free service to help connect people with clinical trials

World Wide Alzheimer's Disease Neuroimaging Initiative (ADNI)

A collaborative effort of scientists from around the world

• JOIN US
  

  ---

• DONATE TODAY
  

  ---

Current Issue  |  January 2013  |  Vol. 9, No. 1

• The worldwide economic impact of dementia 2010
  aging studies
  
• The global prevalence of dementia: A systematic review and metaanalysis
  
• Improving Alzheimer's disease phase II clinical trials
  
• The economics of mild cognitive impairment
  

ABOUT THE JOURNAL

See more milestones

The Alzheimer's Association is committed to accelerating the global effort to eliminate Alzheimer's disease. We are the largest private, nonprofit funder of Alzheimer's research. We believe in the value of collaboration and are willing to imagine a time when we will have disease-modifying treatments, preventive strategies and gold-standard care for all people affected by Alzheimer's disease.

• We fund — We have awarded in excess of $300 million to more than 2,100 projects over the life of our grants program.
• We connect and convene — We provide global forums to advance the field through our international conference, our scientific journal and our professional society.
• We collaborate — We find common ground and partner with our colleagues in government, academia, industry and other nonprofit organizations.
• We advocate — We work to ensure that our policy and publicly funded research initiatives reflect the importance of Alzheimer's disease as a national health priority.
• We seize opportunities — We remain flexible and nimble to identify issues, respond to evolving science and fill gaps.

More about the Alzheimer's Association commitment to research.